Retinoic acid and its analogs (retinoids) stimulate normal human myelopoiesis and erythropoiesis, and inhibit leukemic blast cell clonal proliferation and induce differentiation of leukemic blast cells in vitro. The phenotypic abnormality of human acute myelogenous leukemia is the inability of the leukemic cells to differentiate to functional, non-dividing cells. Preleukemia is a hematopoietic syndrome that preceeds leukemia; the leukemic clone is often established and abnormalities of differentiation are predominant in this disease. The only standard therapy for these patients is supportive. One approach to the therapy of preleukemia (and leukemia) is the induction of differentiation of the neoplastic cells. We are conducting a double blind, randomized trial of administering 13-cis retinoic versus placebo to 80 preleukemia patients in order to determine if the therapy improves their hematopoiesis decreases the size of their neoplastic clone (as determined by karyotypic examinations), and possibly alters the course of their disease. A number of new retinoids have recently been synthesized; these compounds are 10-1000 fold more potent than all trans retinoic acid in several non-hematopoietic assays of inhibition of transformation. We will test the potency of these compounds on clonal growth and induction of differentiation of normal and neoplastic human myeloid progenitor cells in vitro. Treatment of cancer patients with chemotherapy has clearly taught us that a combination of agents is frequently more efficiacious than treatment with a single drug. We shall identify and study compounds that interact synergistically with retinoids to decrease proliferation of leukemia cells and/or to enhance differentiation of leukemia cells. Agents that appear to be effective in vitro frequently are ineffective in vivo. We shall try to develop a murine model to study the effect of retinoids on proliferation of leukemia cells in vivo. Retinoids alter expression of several oncogenes in HL-60 myeloid leukemic cells; we shall examine alterations of chromatin and nuclear matrix in the vicinity of these oncogenes in HL-60 cells exposed to retinoids. An understanding of the process of myeloid differentiation may provide the framework to understand the defect in differentiation of blast cells in leukemia.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA033936-04
Application #
3171675
Study Section
Experimental Therapeutics Subcommittee 2 (ET)
Project Start
1983-02-01
Project End
1989-01-31
Budget Start
1986-03-01
Budget End
1987-01-31
Support Year
4
Fiscal Year
1986
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Type
Schools of Medicine
DUNS #
119132785
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Morosetti, R; Grignani, F; Liberatore, C et al. (1996) Infrequent alterations of the RAR alpha gene in acute myelogenous leukemias, retinoic acid-resistant acute promyelocytic leukemias, myelodysplastic syndromes, and cell lines. Blood 87:4399-403
Kizaki, M; Dawson, M I; Heyman, R et al. (1996) Effects of novel retinoid X receptor-selective ligands on myeloid leukemia differentiation and proliferation in vitro. Blood 87:1977-84
Kizaki, M; Ueno, H; Yamazoe, Y et al. (1996) Mechanisms of retinoid resistance in leukemic cells: possible role of cytochrome P450 and P-glycoprotein. Blood 87:725-33
Akashi, M; Hachiya, M; Osawa, Y et al. (1995) Irradiation induces WAF1 expression through a p53-independent pathway in KG-1 cells. J Biol Chem 270:19181-7
Wada, M; Seeger, R C; Mizoguchi, H et al. (1995) Maintenance of normal imprinting of H19 and IGF2 genes in neuroblastoma. Cancer Res 55:3386-8
Imai, Y; Pike, J W; Koeffler, H P (1995) Potent vitamin D3 analogs: their abilities to enhance transactivation and to bind to the vitamin D3 response element. Leuk Res 19:147-58
Pakkala, S; de Vos, S; Elstner, E et al. (1995) Vitamin D3 analogs: effect on leukemic clonal growth and differentiation, and on serum calcium levels. Leuk Res 19:65-72
Fleischhacker, M; Strohmeyer, T; Imai, Y et al. (1994) Mutations of the p53 gene are not detectable in human testicular tumors. Mod Pathol 7:435-9
Kizaki, M; Nakajima, H; Mori, S et al. (1994) Novel retinoic acid, 9-cis retinoic acid, in combination with all-trans retinoic acid is an effective inducer of differentiation of retinoic acid-resistant HL-60 cells. Blood 83:3289-97
Sakashita, A; Epstein, C J; Carlson, E et al. (1994) Hematopoietic progenitor cells of transgenic mice with increased copper/zinc-superoxide dismutase activity are resistant to tumor necrosis factor. J Cell Physiol 160:233-8

Showing the most recent 10 out of 83 publications